CVE-2024-4176: An Cross site scripting vulnerability in the EDR XConsole before this release allowed an attacker to potential
CVE-2024-4176 is a medium-severity flaw (CVSS 4.1) affecting xconsole. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
An Cross site scripting vulnerability in the EDR XConsole before this release allowed an attacker to potentially leverage an XSS/HTML-Injection using command line variables. A malicious threat actor could execute commands on the victim's browser for sending carefully crafted malicious links to the EDR XConsole end user.
Why this priority
- No elevated risk signals yet
A fixed release or distro patch exists.
Risk facts
| CVSS score | 4.1 (Medium) |
| Attack vector | Network (remote) |
| Attack complexity | Low |
| Privileges needed | Low |
| User interaction | Required |
| EPSS exploit chance | 0.3% (top 76%) |
| CISA exploited list | No |
| Weakness | CWE-79 |
| Published | 2024-06-13 |
| Last modified | 2026-06-17 |
Last updated 2026-06-17 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Am I affected?
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2024-4176?
xconsole: upgrade to newer than 2024-05-17. Exact commands for each OS are on this page.
Is CVE-2024-4176 being exploited?
CVE-2024-4176 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2024-4176 affect?
CVE-2024-4176 affects xconsole. Severity is medium (CVSS 4.1). An Cross site scripting vulnerability in the EDR XConsole before this release allowed an attacker to potentially leverage an XSS/HTML-Injection using command line variables. A malicious threat actor could execute commands on the victim's br
How urgent is CVE-2024-4176?
Priority 20/100. No elevated risk signals yet.